Catalyst Equity Partners is a national investment firm that provides capital to middle market companies going through a restructuring or turnaround. We provide owners and management teams with an uncommon balance of capital resources and business experience to create value for all stakeholders. Our professionals bring extensive experience successfully providing financial, strategic and operational expertise to middle market businesses as investors, directors, advisors, consultants and general managers. We have a strong track record of creating significant value for all stakeholders across a broad portfolio of diverse situations. We manage committed capital in excess of $150 million. Our investors are among the most prominent financial institutions in the world, including: BancBoston Investments, Inc.; Citibank, N.A.; General Electric Capital Corporation; ING Baring (U.S.) Capital Corporation; MetLife Insurance Company of Connecticut; Lexington Partners-Hamilton Lane LLC and St. Paul Travelers Companies, Inc.
http://www.catalysthealthventures.com
Catalyst seeks to forge enduring partnerships with entrepreneurs and co-investors to help create and grow successful businesses from exceptional ideas. We devote the time to understand the entrepreneur's vision, and are prepared to bring our extensive industry experience to the table to realize that vision. Our disciplined, five-tiered investment strategy is analytical, innovative, responsive, accountable, and fundamentally designed to minimize risk and maximize value: Invest early - By investing at the early stage, we have the opportunity to work intimately with management and co-investors to refine and build on a company's development plan and business model. While we typically make our first investment in a start-up at the early stage, we reserve capital for significant support and participation later on. Catalyst typically makes a first investment in the range of $1-3 million, but may invest more or less than that, as appropriate. Generally, we expect to invest a total in the range of $7-12 million in a given portfolio company as it makes progress toward a successful exit. Focus on technology solutions in health care - Our investment focus is on technology-based solutions in health care and the life sciences, rather than pure science. This approach allows us to participate across a spectrum of opportunities without taking on heavy scientific risk. Typical investments include medical devices and technology, life science instrumentation, and diagnostics. Focus locally - We concentrate on opportunities in greater Boston and the northeastern United States. Not only is the Northeast a center of innovation in health care and life science, but focusing on ventures in our own neighborhood allows us to play an active leadership role and leverage our extensive network of relevant industry, academic, and clinical contacts. Take the lead - We believe that taking the lead on our investments is crucial to providing value. Our experience tells us that superior returns are driven by a true partnership between investors and management, requiring active communication, energetic participation, and common goals. Plan for the exit - A successful exit is a goal sought after by investors and entrepreneurs alike. To achieve this goal, a key component to our strategy is to finance companies until they reach financial independence, typically four to seven years. That means we are committed to working with management and co-investors to prepare each company for steady and growing revenues and profits. We plan for this goal at the outset and make subsequent financing decisions with an eye toward their impact on achieving the company's exit strategy.
The Center for Emerging Technologies (CET) provides the specialized facilities, knowledgeable support services, entrepreneur training programs, and access to capital needed to establish and develop next generation medical and other advanced technology companies. In only nine years, CET has grown to encompass 92,000 SF of incubator/accelerator space in two rehabbed buildings, with a new 60,000 SF lab building under development. CET companies have obtained $804 million in funding from investors, grants and revenues. CET has been a key member of a St. Louis public-private-three university partnership focused on creating all of the elements needed to commercialize innovations through new companies, grow a competitive life science industry cluster, and be a leading center of tech-based economic development. CET staff members have been actively engaged in national initiatives to devise and promote best practices for funding translational research and development, technology transfer, biomedical incubators, and university-industry-small company research collaborations.
We offer early-stage investment and back that financial investment with a human commitment, providing the involvement and experience necessary to make a new business a reality , quickly and efficiently. Our focus is on enterprise software, with an emphasis on infrastructure technologies, supply chain solutions and collaboration platforms. We concentrate on early-stage opportunities and invest in people as well as ideas, recognizing that the best of ideas can only be realized through talent and commitment. We are not just ordinary venture capitalists. Our goal is to invest in a relatively small number of companies per year and to stay sufficiently involved and focused to maximize their success. Drawing upon years of business experience in the Internet and high-tech worlds, our partners provide proven perspective and counsel on the challenges facing a startup business: fine-tuning a business plan; developing a powerful, sustainable business model; creating a realistic financial plan; developing scalable technology; creating a strategic marketing plan; recruiting top talent; and, in general, ensuring that all key strategic and business issues are fully addressed. Founded by 5 Silicon Valley entrepreneurs, Wingspring offers support in all areas of business development. Wingspring has but one mission: to invest in promising early-stage opportunities and to work actively, in partnership with our entrepreneurs, to realize the full potential of those investments.
Glengary is a venture catalyst enterprise that provides a unique combination of resources to enable its client companies to achieve commercial success. Glengary focuses on the process of growing its early-stage client companies through the effective management of resources, aligning agendas and the achievement of developmental milestones, resulting in the material increase in enterprise value. Glengary recognizes that most early-stage companies can be assisted in two critical areas: cash and talent. Typically, early-stage companies are unable to attract enough cash resources to hire and retain the talent required to increase their chances of success. In fact, many early-stage companies make the mistake of hiring who they can afford, not who they need! To mitigate the human-capital risk, Glengary provides highly qualified and successful management team members to its client companies. Since the provision of such management team members is done on a part-time basis, we can furnish the talent at a fraction of the cash cost of a comparable hire. Beyond Glengary's provision of management team members to complement the existing client company management, Glengary can add value at the board level, with day-to-day operations, technology development, assistance with sales and marketing, strategy and fundraising. Glengary differentiates itself from a consulting firm by taking equity risk in two ways: first, Glengary makes cash investments in its client companies in return for equity; second, Glengary will provide its services at below cash market value in return for at-risk sweat equity. By taking an at-risk position with our client companies, we align our interests with the other stakeholders of our client companies with the common goal of increasing enterprise value.
Debi Rosati acts as a venture catalyst --- providing strategic financing advice to start-up technology companies. venture catalyst, venture catalyst firm, financing strategies for technology start-ups, investor ready, financing early stage technology companies, strategic financing, creative financing.
Catalyst develops and funds fast growth technology companies. Our approach depends upon the stage of the company and the type of proposition: Early stage (i.e. pre-profitable part proven business concept with a core management team). We use our accelerator programme to develop these businesses. This involves, introducing trophy customers, identifying investor directors, accessing our private investor base of over 400 individuals and early stage institutional funding. Expansion stage funding (i.e. profitable, proven concept) This involves preparing the business for investment, developing funding documentation, developing a shortlist of funders, creating a competitive process, negotiating and managing the deal to completion. Management Buy Outs/Buy Ins. We work with management teams to help them finance and negotiate the acquisition of companies. This involves negotiating with vendors, raising the equity and debt finance, managing the deal through to completion.
http://www.catalystinvestors.com
Catalyst Investors is a private equity fund that provides equity capital to companies in the media, communications and related Internet services industries. We focus on growth areas within the middle market, investing $5 to $30 million alongside management teams to fund expansion, acquisitions or recapitalizations. In certain cases we form companies around talented managers in proven areas where we see opportunity. In addition to capital, we bring extensive industry experience and a broad network of relationships to each investment. We are based in New York and make investments primarily in the U.S. and Canada.
Global Catalyst Partners is an international, multistage, technology-oriented venture capital firm. Our partners have significant operating experience serving in large public companies as well as building entrepreneurial ventures into major public companies. It is GCP's view that all ventures must be global upon inception, optimizing inputs (manufacturing, technology sourcing, financing) and opportunities. Accordingly, GCP has a single fund and operates with a single team assisting each of its ventures globally. GCP has extensive strategic corporate relationships to help companies recruit, source technology, obtain services, and most importantly identify appropriate customers. Apart from our broad U.S. portfolio, we have financed companies based in China, Israel and Japan. We welcome entrepreneurs to share their business plans with us at plans@gc-partners.com.
Sherpa, which was founded by Lewis in 1997, previously invested about $5 million from three partners in local start-up companies. Among its local investments are Eden Prairie-based Xiotech Corp., a network computer storage firm that was acquired by Seagate Technology, and marketing software firm Cognicity Inc. of Edina. Using the new $15 million fund, Sherpa's average investment in a start-up company will be about $1 million, and the maximum investment will be $3 million to $4 million, Lewis said. That means that as these companies grow, they will have to attract investment from venture capital funds other than Sherpa. While Sherpa's fund managers hope to create long-lasting companies in the state, they concede that in the near term they are more likely to be funding start-ups which, if successful, will be acquired by larger, established companies in other parts of the country. Right now, the sale of a company is the best way for the original investors to recover their investment plus a profit because the stock market isn't favorable for initial public offerings. Sherpa has been what Pederson called an "incubator stage" investor, but with the new fund it will wait until later in a company's life cycle to invest, he said. To qualify for the venture capital funds, companies already should have acquired good management, attracted some private funding or, in some cases, started selling a product. But the best thing about the new venture fund is that will allow Sherpa to think about making bigger investments, Pederson said. "Two years ago we would have had to scrape to raise $1 million to $2 million. Now we can offer a larger fund," Pederson said.
Primaxis is an early stage Venture Capital fund. We invest in leading-edge opportunities in the physical and engineering sciences. We work in close partnership with technology inventors and entrepreneurs to build high growth companies. The Primaxis team includes entrepreneurs, scientists and engineers, and business executives, who bring sector expertise, broad operational experience and vision to our partner companies. We work with company founders to build value in fundamental and strategic areas such as technology development, intellectual property management, business development, human resources and corporate governance.
Privacy Policy | Terms and Conditions | Do Not Sell My Personal Information | Websites Directory
Copyright © 2022 kwtbox.com. All Rights Reserved. US Business Directory